TESTOSTERONE

Clinical Indication

Gender reassignment

Comments

To be used and monitored in line with guidance/written information from specialist centre consultant/team (nearest clinic is in Nottinghamshire*)
(NB no formal SCA in place but written guidance from specialist)
Gender dysphoria services: a guide for GPs and other healthcare professionals

Date of classification

September 2015

Orange

Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.